Global Human Gene Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 239 pages | ID: G10F4562898EEN
Bosson Research

Abstracts

Report Overview

Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.

This report provides a deep insight into the global Human Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Gene Therapy market in any manner.

Global Human Gene Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biogen

Sarepta Therapeutics

Gilead Sciences

Amgen

Novartis

Orchard Therapeutics

Spark Therapeutics

Agc Biologics

Anges

Bluebird Bio

Jazz Pharmaceuticals

Dynavax Technologies

Human Stem Cells Institute

Sibiono Genetech

Shanghai Sunway Biotech

Uniqure N.V.

Gensight Biologics S.A.

Celgene Corporation

Cellectis

Sangamo Therapeutics

Mustang Bio

AGTC

Poseida Therapeutics

Market Segmentation (by Type)

Non-viral Vectors

Viral Vectors

Market Segmentation (by Application)

Neurological Diseases

Cancer

DMD (Duchenne Muscular Dystrophy)

Hepatological Diseases

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Human Gene Therapy Market
• Overview of the regional outlook of the Human Gene Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Gene Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Gene Therapy
1.2 Key Market Segments
1.2.1 Human Gene Therapy Segment by Type
1.2.2 Human Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Human Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Human Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Human Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Human Gene Therapy Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Human Gene Therapy Product Life Cycle
3.3 Global Human Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Human Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Human Gene Therapy Manufacturing Sites, Area Served, Product Type
3.8 Human Gene Therapy Market Competitive Situation and Trends
3.8.1 Human Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Human Gene Therapy Industry Chain Analysis
4.1 Human Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Human Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 Global Human Gene Therapy Market by Region
6.1 Global Human Gene Therapy Market Size by Region
6.1.1 Global Human Gene Therapy Market Size by Region
6.1.2 Global Human Gene Therapy Market Size Market Share by Region
6.2 Global Human Gene Therapy Sales by Region
6.2.1 Global Human Gene Therapy Sales by Region
6.2.2 Global Human Gene Therapy Sales Market Share by Region
7 North America Market Overview
7.1 North America Human Gene Therapy Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Human Gene Therapy Market Size by Type
7.3 North America Human Gene Therapy Market Size by Application
8 Europe Market Overview
8.1 Europe Human Gene Therapy Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Human Gene Therapy Market Size by Type
8.3 Europe Human Gene Therapy Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Human Gene Therapy Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Human Gene Therapy Market Size by Type
9.3 Asia-Pacific Human Gene Therapy Market Size by Application
10 South America Market Overview
10.1 South America Human Gene Therapy Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Human Gene Therapy Market Size by Type
10.3 South America Human Gene Therapy Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Human Gene Therapy Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Human Gene Therapy Market Size by Type
11.3 Middle East and Africa Human Gene Therapy Market Size by Application
12 Human Gene Therapy Market Production by Region
12.1 Global Production of Human Gene Therapy by Region(2020-2025)
12.2 Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
12.3 Global Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Human Gene Therapy Production
12.4.1 North America Human Gene Therapy Production Growth Rate (2020-2025)
12.4.2 North America Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Human Gene Therapy Production
12.5.1 Europe Human Gene Therapy Production Growth Rate (2020-2025)
12.5.2 Europe Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Human Gene Therapy Production (2020-2025)
12.6.1 Japan Human Gene Therapy Production Growth Rate (2020-2025)
12.6.2 Japan Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Human Gene Therapy Production (2020-2025)
12.7.1 China Human Gene Therapy Production Growth Rate (2020-2025)
12.7.2 China Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
13 Human Gene Therapy Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Human Gene Therapy Sales Market Share by Type (2020-2033)
13.3 Global Human Gene Therapy Market Size Market Share by Type (2020-2033)
13.4 Global Human Gene Therapy Price by Type (2020-2033)
14 Human Gene Therapy Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Human Gene Therapy Market Sales by Application (2020-2033)
14.3 Global Human Gene Therapy Market Size (M USD) by Application (2020-2033)
14.4 Global Human Gene Therapy Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Biogen
15.1.1 Biogen Basic Information
15.1.2 Biogen Human Gene Therapy Product Overview
15.1.3 Biogen Human Gene Therapy Product Market Performance
15.1.4 Biogen Business Overview
15.1.5 Biogen SWOT Analysis
15.1.6 Biogen Recent Developments
15.2 Sarepta Therapeutics
15.2.1 Sarepta Therapeutics Basic Information
15.2.2 Sarepta Therapeutics Human Gene Therapy Product Overview
15.2.3 Sarepta Therapeutics Human Gene Therapy Product Market Performance
15.2.4 Sarepta Therapeutics Business Overview
15.2.5 Sarepta Therapeutics SWOT Analysis
15.2.6 Sarepta Therapeutics Recent Developments
15.3 Gilead Sciences
15.3.1 Gilead Sciences Basic Information
15.3.2 Gilead Sciences Human Gene Therapy Product Overview
15.3.3 Gilead Sciences Human Gene Therapy Product Market Performance
15.3.4 Gilead Sciences Business Overview
15.3.5 Gilead Sciences SWOT Analysis
15.3.6 Gilead Sciences Recent Developments
15.4 Amgen
15.4.1 Amgen Basic Information
15.4.2 Amgen Human Gene Therapy Product Overview
15.4.3 Amgen Human Gene Therapy Product Market Performance
15.4.4 Amgen Business Overview
15.4.5 Amgen Recent Developments
15.5 Novartis
15.5.1 Novartis Basic Information
15.5.2 Novartis Human Gene Therapy Product Overview
15.5.3 Novartis Human Gene Therapy Product Market Performance
15.5.4 Novartis Business Overview
15.5.5 Novartis Recent Developments
15.6 Orchard Therapeutics
15.6.1 Orchard Therapeutics Basic Information
15.6.2 Orchard Therapeutics Human Gene Therapy Product Overview
15.6.3 Orchard Therapeutics Human Gene Therapy Product Market Performance
15.6.4 Orchard Therapeutics Business Overview
15.6.5 Orchard Therapeutics Recent Developments
15.7 Spark Therapeutics
15.7.1 Spark Therapeutics Basic Information
15.7.2 Spark Therapeutics Human Gene Therapy Product Overview
15.7.3 Spark Therapeutics Human Gene Therapy Product Market Performance
15.7.4 Spark Therapeutics Business Overview
15.7.5 Spark Therapeutics Recent Developments
15.8 Agc Biologics
15.8.1 Agc Biologics Basic Information
15.8.2 Agc Biologics Human Gene Therapy Product Overview
15.8.3 Agc Biologics Human Gene Therapy Product Market Performance
15.8.4 Agc Biologics Business Overview
15.8.5 Agc Biologics Recent Developments
15.9 Anges
15.9.1 Anges Basic Information
15.9.2 Anges Human Gene Therapy Product Overview
15.9.3 Anges Human Gene Therapy Product Market Performance
15.9.4 Anges Business Overview
15.9.5 Anges Recent Developments
15.10 Bluebird Bio
15.10.1 Bluebird Bio Basic Information
15.10.2 Bluebird Bio Human Gene Therapy Product Overview
15.10.3 Bluebird Bio Human Gene Therapy Product Market Performance
15.10.4 Bluebird Bio Business Overview
15.10.5 Bluebird Bio Recent Developments
15.11 Jazz Pharmaceuticals
15.11.1 Jazz Pharmaceuticals Basic Information
15.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Overview
15.11.3 Jazz Pharmaceuticals Human Gene Therapy Product Market Performance
15.11.4 Jazz Pharmaceuticals Business Overview
15.11.5 Jazz Pharmaceuticals Recent Developments
15.12 Dynavax Technologies
15.12.1 Dynavax Technologies Basic Information
15.12.2 Dynavax Technologies Human Gene Therapy Product Overview
15.12.3 Dynavax Technologies Human Gene Therapy Product Market Performance
15.12.4 Dynavax Technologies Business Overview
15.12.5 Dynavax Technologies Recent Developments
15.13 Human Stem Cells Institute
15.13.1 Human Stem Cells Institute Basic Information
15.13.2 Human Stem Cells Institute Human Gene Therapy Product Overview
15.13.3 Human Stem Cells Institute Human Gene Therapy Product Market Performance
15.13.4 Human Stem Cells Institute Business Overview
15.13.5 Human Stem Cells Institute Recent Developments
15.14 Sibiono Genetech
15.14.1 Sibiono Genetech Basic Information
15.14.2 Sibiono Genetech Human Gene Therapy Product Overview
15.14.3 Sibiono Genetech Human Gene Therapy Product Market Performance
15.14.4 Sibiono Genetech Business Overview
15.14.5 Sibiono Genetech Recent Developments
15.15 Shanghai Sunway Biotech
15.15.1 Shanghai Sunway Biotech Basic Information
15.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Overview
15.15.3 Shanghai Sunway Biotech Human Gene Therapy Product Market Performance
15.15.4 Shanghai Sunway Biotech Business Overview
15.15.5 Shanghai Sunway Biotech Recent Developments
15.16 Uniqure N.V.
15.16.1 Uniqure N.V. Basic Information
15.16.2 Uniqure N.V. Human Gene Therapy Product Overview
15.16.3 Uniqure N.V. Human Gene Therapy Product Market Performance
15.16.4 Uniqure N.V. Business Overview
15.16.5 Uniqure N.V. Recent Developments
15.17 Gensight Biologics S.A.
15.17.1 Gensight Biologics S.A. Basic Information
15.17.2 Gensight Biologics S.A. Human Gene Therapy Product Overview
15.17.3 Gensight Biologics S.A. Human Gene Therapy Product Market Performance
15.17.4 Gensight Biologics S.A. Business Overview
15.17.5 Gensight Biologics S.A. Recent Developments
15.18 Celgene Corporation
15.18.1 Celgene Corporation Basic Information
15.18.2 Celgene Corporation Human Gene Therapy Product Overview
15.18.3 Celgene Corporation Human Gene Therapy Product Market Performance
15.18.4 Celgene Corporation Business Overview
15.18.5 Celgene Corporation Recent Developments
15.19 Cellectis
15.19.1 Cellectis Basic Information
15.19.2 Cellectis Human Gene Therapy Product Overview
15.19.3 Cellectis Human Gene Therapy Product Market Performance
15.19.4 Cellectis Business Overview
15.19.5 Cellectis Recent Developments
15.20 Sangamo Therapeutics
15.20.1 Sangamo Therapeutics Basic Information
15.20.2 Sangamo Therapeutics Human Gene Therapy Product Overview
15.20.3 Sangamo Therapeutics Human Gene Therapy Product Market Performance
15.20.4 Sangamo Therapeutics Business Overview
15.20.5 Sangamo Therapeutics Recent Developments
15.21 Mustang Bio
15.21.1 Mustang Bio Basic Information
15.21.2 Mustang Bio Human Gene Therapy Product Overview
15.21.3 Mustang Bio Human Gene Therapy Product Market Performance
15.21.4 Mustang Bio Business Overview
15.21.5 Mustang Bio Recent Developments
15.22 AGTC
15.22.1 AGTC Basic Information
15.22.2 AGTC Human Gene Therapy Product Overview
15.22.3 AGTC Human Gene Therapy Product Market Performance
15.22.4 AGTC Business Overview
15.22.5 AGTC Recent Developments
15.23 Poseida Therapeutics
15.23.1 Poseida Therapeutics Basic Information
15.23.2 Poseida Therapeutics Human Gene Therapy Product Overview
15.23.3 Poseida Therapeutics Human Gene Therapy Product Market Performance
15.23.4 Poseida Therapeutics Business Overview
15.23.5 Poseida Therapeutics Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Gene Therapy Market Size by Type (M USD)
Table 4. Global Human Gene Therapy Market Size by Application (M USD)
Table 5. Human Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Human Gene Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2024)
Table 11. Global Market Human Gene Therapy Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Human Gene Therapy Manufacturing Sites and Area Served
Table 13. Manufacturers Human Gene Therapy Product Type
Table 14. Global Human Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Human Gene Therapy Market Size Comparison by Region (M USD)
Table 26. Global Human Gene Therapy Market Size by Region (2020-2033) & (M USD)
Table 27. Global Human Gene Therapy Market Size Market Share by Region (2020-2033)
Table 28. Global Human Gene Therapy Sales by Region (2020-2033) & (K MT)
Table 29. Global Human Gene Therapy Sales Market Share by Region (2020-2033)
Table 30. North America Human Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 31. North America Human Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 32. North America Human Gene Therapy Sales by Type (K MT)
Table 33. North America Human Gene Therapy Market Size by Type (M USD)
Table 34. North America Human Gene Therapy Sales (K MT) by Type (2020-2033)
Table 35. North America Human Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 36. North America Human Gene Therapy Sales by Application (K MT)
Table 37. North America Human Gene Therapy Market Size by Application (M USD)
Table 38. North America Human Gene Therapy Sales (K MT) by Application (2020-2033)
Table 39. North America Human Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 40. Europe Human Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Human Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 42. Europe Human Gene Therapy Sales by Type (K MT)
Table 43. Europe Human Gene Therapy Market Size by Type (M USD)
Table 44. Europe Human Gene Therapy Sales (K MT) by Type (2020-2033)
Table 45. Europe Human Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 46. Europe Human Gene Therapy Sales by Application (K MT)
Table 47. Europe Human Gene Therapy Market Size by Application (M USD)
Table 48. Europe Human Gene Therapy Sales (K MT) by Application (2020-2033)
Table 49. Europe Human Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Human Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Human Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Human Gene Therapy Sales by Type (K MT)
Table 53. Asia-Pacific Human Gene Therapy Market Size by Type (M USD)
Table 54. Asia-Pacific Human Gene Therapy Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Human Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Human Gene Therapy Sales by Application (K MT)
Table 57. Asia-Pacific Human Gene Therapy Market Size by Application (M USD)
Table 58. Asia-Pacific Human Gene Therapy Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Human Gene Therapy Market Size (M USD) by Application (2020-2025)
Table 60. South America Human Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 61. South America Human Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 62. South America Human Gene Therapy Sales by Type (K MT)
Table 63. South America Human Gene Therapy Market Size by Type (M USD)
Table 64. South America Human Gene Therapy Sales (K MT) by Type (2020-2033)
Table 65. South America Human Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 66. South America Human Gene Therapy Sales by Application (K MT)
Table 67. South America Human Gene Therapy Market Size by Application (M USD)
Table 68. South America Human Gene Therapy Sales (K MT) by Application (2020-2033)
Table 69. South America Human Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Human Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Human Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Human Gene Therapy Sales by Type (K MT)
Table 73. Middle East and Africa Human Gene Therapy Market Size by Type (M USD)
Table 74. Middle East and Africa Human Gene Therapy Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Human Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Human Gene Therapy Sales by Application (K MT)
Table 77. Middle East and Africa Human Gene Therapy Market Size by Application (M USD)
Table 78. Middle East and Africa Human Gene Therapy Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Human Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 80. Global Human Gene Therapy Production (K MT) by Region(2020-2025)
Table 81. Global Human Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
Table 83. Global Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Human Gene Therapy Sales by Type (K MT)
Table 89. Global Human Gene Therapy Market Size by Type (M USD)
Table 90. Global Human Gene Therapy Sales (K MT) by Type (2020-2033)
Table 91. Global Human Gene Therapy Sales Market Share by Type (2020-2033)
Table 92. Global Human Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 93. Global Human Gene Therapy Market Size Share by Type (2020-2033)
Table 94. Global Human Gene Therapy Sales (K MT) by Application
Table 95. Global Human Gene Therapy Market Size by Application(M USD)
Table 96. Global Human Gene Therapy Sales by Application (2020-2033) & (K MT)
Table 97. Global Human Gene Therapy Sales Market Share by Application (2020-2033)
Table 98. Global Human Gene Therapy Market Size by Application (2020-2033) & (M USD)
Table 99. Global Human Gene Therapy Market Share by Application (2020-2033)
Table 100. Global Human Gene Therapy Sales Growth Rate by Application (2020-2033)
Table 101. Biogen Basic Information
Table 102. Biogen Human Gene Therapy Product Overview
Table 103. Biogen Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Biogen Business Overview
Table 105. Biogen SWOT Analysis
Table 106. Biogen Recent Developments
Table 107. Sarepta Therapeutics Basic Information
Table 108. Sarepta Therapeutics Human Gene Therapy Product Overview
Table 109. Sarepta Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Sarepta Therapeutics Business Overview
Table 111. Sarepta Therapeutics SWOT Analysis
Table 112. Sarepta Therapeutics Recent Developments
Table 113. Gilead Sciences Basic Information
Table 114. Gilead Sciences Human Gene Therapy Product Overview
Table 115. Gilead Sciences Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Gilead Sciences Business Overview
Table 117. Gilead Sciences SWOT Analysis
Table 118. Gilead Sciences Recent Developments
Table 119. Amgen Basic Information
Table 120. Amgen Human Gene Therapy Product Overview
Table 121. Amgen Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Amgen Business Overview
Table 123. Amgen Recent Developments
Table 124. Novartis Basic Information
Table 125. Novartis Human Gene Therapy Product Overview
Table 126. Novartis Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Novartis Business Overview
Table 128. Novartis Recent Developments
Table 129. Orchard Therapeutics Basic Information
Table 130. Orchard Therapeutics Human Gene Therapy Product Overview
Table 131. Orchard Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Orchard Therapeutics Business Overview
Table 133. Orchard Therapeutics Recent Developments
Table 134. Spark Therapeutics Basic Information
Table 135. Spark Therapeutics Human Gene Therapy Product Overview
Table 136. Spark Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Spark Therapeutics Business Overview
Table 138. Spark Therapeutics Recent Developments
Table 139. Agc Biologics Basic Information
Table 140. Agc Biologics Human Gene Therapy Product Overview
Table 141. Agc Biologics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Agc Biologics Business Overview
Table 143. Agc Biologics Recent Developments
Table 144. Anges Basic Information
Table 145. Anges Human Gene Therapy Product Overview
Table 146. Anges Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Anges Business Overview
Table 148. Anges Recent Developments
Table 149. Bluebird Bio Basic Information
Table 150. Bluebird Bio Human Gene Therapy Product Overview
Table 151. Bluebird Bio Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Bluebird Bio Business Overview
Table 153. Bluebird Bio Recent Developments
Table 154. Jazz Pharmaceuticals Basic Information
Table 155. Jazz Pharmaceuticals Human Gene Therapy Product Overview
Table 156. Jazz Pharmaceuticals Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Jazz Pharmaceuticals Business Overview
Table 158. Jazz Pharmaceuticals Recent Developments
Table 159. Dynavax Technologies Basic Information
Table 160. Dynavax Technologies Human Gene Therapy Product Overview
Table 161. Dynavax Technologies Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Dynavax Technologies Business Overview
Table 163. Dynavax Technologies Recent Developments
Table 164. Human Stem Cells Institute Basic Information
Table 165. Human Stem Cells Institute Human Gene Therapy Product Overview
Table 166. Human Stem Cells Institute Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Human Stem Cells Institute Business Overview
Table 168. Human Stem Cells Institute Recent Developments
Table 169. Sibiono Genetech Basic Information
Table 170. Sibiono Genetech Human Gene Therapy Product Overview
Table 171. Sibiono Genetech Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Sibiono Genetech Business Overview
Table 173. Sibiono Genetech Recent Developments
Table 174. Shanghai Sunway Biotech Basic Information
Table 175. Shanghai Sunway Biotech Human Gene Therapy Product Overview
Table 176. Shanghai Sunway Biotech Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Shanghai Sunway Biotech Business Overview
Table 178. Shanghai Sunway Biotech Recent Developments
Table 179. Uniqure N.V. Basic Information
Table 180. Uniqure N.V. Human Gene Therapy Product Overview
Table 181. Uniqure N.V. Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Uniqure N.V. Business Overview
Table 183. Uniqure N.V. Recent Developments
Table 184. Gensight Biologics S.A. Basic Information
Table 185. Gensight Biologics S.A. Human Gene Therapy Product Overview
Table 186. Gensight Biologics S.A. Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Gensight Biologics S.A. Business Overview
Table 188. Gensight Biologics S.A. Recent Developments
Table 189. Celgene Corporation Basic Information
Table 190. Celgene Corporation Human Gene Therapy Product Overview
Table 191. Celgene Corporation Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Celgene Corporation Business Overview
Table 193. Celgene Corporation Recent Developments
Table 194. Cellectis Basic Information
Table 195. Cellectis Human Gene Therapy Product Overview
Table 196. Cellectis Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Cellectis Business Overview
Table 198. Cellectis Recent Developments
Table 199. Sangamo Therapeutics Basic Information
Table 200. Sangamo Therapeutics Human Gene Therapy Product Overview
Table 201. Sangamo Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. Sangamo Therapeutics Business Overview
Table 203. Sangamo Therapeutics Recent Developments
Table 204. Mustang Bio Basic Information
Table 205. Mustang Bio Human Gene Therapy Product Overview
Table 206. Mustang Bio Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Mustang Bio Business Overview
Table 208. Mustang Bio Recent Developments
Table 209. AGTC Basic Information
Table 210. AGTC Human Gene Therapy Product Overview
Table 211. AGTC Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. AGTC Business Overview
Table 213. AGTC Recent Developments
Table 214. Poseida Therapeutics Basic Information
Table 215. Poseida Therapeutics Human Gene Therapy Product Overview
Table 216. Poseida Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 217. Poseida Therapeutics Business Overview
Table 218. Poseida Therapeutics Recent Developments
List of Figures
Figure 1. Product Picture of Human Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Human Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Human Gene Therapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Gene Therapy Product Life Cycle
Figure 13. Human Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Human Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Human Gene Therapy Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Human Gene Therapy
Figure 19. Global Human Gene Therapy Market PEST Analysis
Figure 20. Global Human Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Human Gene Therapy Market Size by Region
Figure 27. Global Human Gene Therapy Market Size Market Share by Region (2020-2033)
Figure 28. Global Human Gene Therapy Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Human Gene Therapy Market Size (M USD) by Country
Figure 33. USA Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Human Gene Therapy Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Human Gene Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Human Gene Therapy Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Human Gene Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Human Gene Therapy Market Size (M USD)by Type
Figure 40. North America Human Gene Therapy Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Human Gene Therapy Market Size (M USD) by Country
Figure 45. Germany Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Human Gene Therapy Market Size (M USD) by Type
Figure 56. Europe Human Gene Therapy Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Human Gene Therapy Market Size (M USD) by Country
Figure 61. China Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Human Gene Therapy Market Size (M USD) by Type
Figure 72. Asia-Pacific Human Gene Therapy Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Human Gene Therapy Market Size (M USD) by Country
Figure 77. Brazil Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Human Gene Therapy Market Size (M USD) by Type
Figure 84. South America Human Gene Therapy Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Human Gene Therapy Market Size (M USD) by Country
Figure 89. Saudi Arabia Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Human Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Human Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Human Gene Therapy Market Size (M USD) by Type
Figure 100. Middle East and Africa Human Gene Therapy Market Size (M USD) by Application
Figure 101. Global Human Gene Therapy Production Market Share by Region (2020-2025)
Figure 102. North America Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. China Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Human Gene Therapy Market Size by Type (M USD)
Figure 108. Sales Market Share of Human Gene Therapy by Type (2020-2033)
Figure 109. Sales Market Share of Human Gene Therapy by Type in 2024
Figure 110. Market Size Share of Human Gene Therapy by Type (2020-2033)
Figure 111. Market Size Share of Human Gene Therapy by Type in 2024
Figure 112. Global Human Gene Therapy Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Human Gene Therapy Market Size by Application(M USD)
Figure 115. Global Human Gene Therapy Market Share by Application
Figure 116. Global Human Gene Therapy Sales Market Share by Application (2020-2033)
Figure 117. Global Human Gene Therapy Sales Market Share by Application in 2024
Figure 118. Global Human Gene Therapy Market Share by Application (2020-2033)
Figure 119. Global Human Gene Therapy Market Share by Application in 2024
Figure 120. Global Human Gene Therapy Sales Growth Rate by Application (2020-2033)